Trial Profile
Molecular mechanism and further treatment of Apatinib resistance in advanced gastric cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 Aug 2018 New trial record